Transforming growth factor (TGF)-β signaling is important for EMT and the expression of ZEB173; treatment with the TGF-β1 resulted in increased levels of ZEB1 expression, while decreasing the level of miR-340 in BC 29. This evidence concerns the gene ZEB1 and breast cancer.